Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cerulean Pharma Inc announces closing of initial public offering


Tuesday, 15 Apr 2014 10:50am EDT 

Cerulean Pharma Inc:Closing of initial public offering of 8,500,000 shares of common stock at a public offering price of $7 per share, before underwriting discounts.Leerink Partners acted as sole book-running manager for the offering.Canaccord Genuity, JMP Securities and Wedbush PacGrow Life Sciences acted as co-managers for the offering. 

Latest Developments for Cerulean Pharma Inc